Milestone Pharmaceuticals: Q4 Earnings Insights

Milestone Pharmaceuticals MIST reported its Q4 earnings results on Thursday, March 21, 2024 at 07:14 AM.

Here's what investors need to know about the announcement.

Earnings

Milestone Pharmaceuticals missed estimated earnings by -3.0%, reporting an EPS of $-0.32 versus an estimate of $-0.31.

Revenue was down $3.50 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 4.0% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Milestone Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.